Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Premkumar Christadoss

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Neuroimmunology|May 6, 2008
C5a is not involved in experimental autoimmune myasthenia gravis pathogenesisHuibin Qi, Erdem Tüzün, Windy Allman, et al.
Journal of Neuroimmunology|January 1, 2003
Suppressed clinical experimental autoimmune myasthenia gravis in bm12 mice is linked to reduced intracellular calcium mobilization and IL-10 and IFN-gamma release by acetylcholine receptor-specific T cellsMathilde A Poussin, Claudette L Fuller, Elzbieta Goluszko, et al.
Journal of Neuroimmunology|January 22, 2008
Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesisJing Li, Erdem Tüzün, Xiong Rong Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Circulating immune complexes augment severity of antibody-mediated myasthenia gravis in hypogammaglobulinemic RIIIS/J miceErdem Tüzün, Benjamin G Scott, Huan Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravisMathilde A Poussin, Erdem Tüzün, Elzbieta Goluszko, et al.
Muscle & Nerve|January 17, 2012
Ocular and generalized myasthenia gravis induced by human acetylcholine receptor γ subunit immunizationXiaorong Wu, Erdem Tuzun, Jing Li, et al.
Journal of Neuroimmunology|April 13, 2011
Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesisHuibin Qi, Jing Li, Windy Allman, et al.
Clinical EEG and Neuroscience|August 26, 2006
Autoimmune thyroid encephalopathy presenting with epilepsia partialis continuaZeynep Aydin-Ozemir, Erdem Tüzün, Betül Baykan, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 22, 2009
Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profileHuan Yang, Yong Zhang, Minghua Wu, et al.
Journal of Neuroimmunology|May 14, 2003
Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravisCaishu Deng, Bo Wu, Huan Yang, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Neuroimmunology|May 6, 2008
C5a is not involved in experimental autoimmune myasthenia gravis pathogenesisHuibin Qi, Erdem Tüzün, Windy Allman, et al.
Journal of Neuroimmunology|January 1, 2003
Suppressed clinical experimental autoimmune myasthenia gravis in bm12 mice is linked to reduced intracellular calcium mobilization and IL-10 and IFN-gamma release by acetylcholine receptor-specific T cellsMathilde A Poussin, Claudette L Fuller, Elzbieta Goluszko, et al.
Journal of Neuroimmunology|January 22, 2008
Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesisJing Li, Erdem Tüzün, Xiong Rong Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Circulating immune complexes augment severity of antibody-mediated myasthenia gravis in hypogammaglobulinemic RIIIS/J miceErdem Tüzün, Benjamin G Scott, Huan Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravisMathilde A Poussin, Erdem Tüzün, Elzbieta Goluszko, et al.
Muscle & Nerve|January 17, 2012
Ocular and generalized myasthenia gravis induced by human acetylcholine receptor γ subunit immunizationXiaorong Wu, Erdem Tuzun, Jing Li, et al.
Journal of Neuroimmunology|April 13, 2011
Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesisHuibin Qi, Jing Li, Windy Allman, et al.
Clinical EEG and Neuroscience|August 26, 2006
Autoimmune thyroid encephalopathy presenting with epilepsia partialis continuaZeynep Aydin-Ozemir, Erdem Tüzün, Betül Baykan, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 22, 2009
Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profileHuan Yang, Yong Zhang, Minghua Wu, et al.
Journal of Neuroimmunology|May 14, 2003
Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravisCaishu Deng, Bo Wu, Huan Yang, et al.
Pageof 6